Literature DB >> 14533984

C-reactive protein in the diagnosis of community-acquired pneumonia.

Henry I Z Requejo1, Ana Maria Cocoza.   

Abstract

Qualitative determination of C-reactive protein (CRP) was evaluated as a diagnostic method for community-acquired pneumonia. Paired serum and pleural fluid samples from child patients were examined with a CRP test, compared to bacterial cultures, counterimmunoelectrophoresis and immunoassay. The CRP test gave excellent parameters of sensitivity, specificity and predictive values for the diagnosis of bacterial pneumonia.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14533984     DOI: 10.1590/s1413-86702003000400003

Source DB:  PubMed          Journal:  Braz J Infect Dis        ISSN: 1413-8670            Impact factor:   1.949


  5 in total

Review 1.  Diagnostic value of C reactive protein in infections of the lower respiratory tract: systematic review.

Authors:  Victor van der Meer; Arie Knuistingh Neven; Peterhans J van den Broek; Willem J J Assendelft
Journal:  BMJ       Date:  2005-06-24

2.  Expression, regulation and clinical significance of soluble and membrane CD14 receptors in pediatric inflammatory lung diseases.

Authors:  Veronica Marcos; Phillip Latzin; Andreas Hector; Sebastian Sonanini; Florian Hoffmann; Martin Lacher; Barbara Koller; Philip Bufler; Thomas Nicolai; Dominik Hartl; Matthias Griese
Journal:  Respir Res       Date:  2010-03-19

3.  The association of positive chest radiograph and laboratory parameters with community acquired pneumonia in children.

Authors:  Dhairya Lakhani; Prasad Muley
Journal:  J Clin Diagn Res       Date:  2013-08-01

Review 4.  Management of acute bronchitis in healthy adults.

Authors:  Eva Aagaard; Ralph Gonzales
Journal:  Infect Dis Clin North Am       Date:  2004-12       Impact factor: 5.982

5.  Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course.

Authors:  Luís Coelho; Pedro Póvoa; Eduardo Almeida; Antero Fernandes; Rui Mealha; Pedro Moreira; Henrique Sabino
Journal:  Crit Care       Date:  2007       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.